Journal article
Surrogate outcomes: experiences at the Common Drug Review
Abstract
BackgroundSurrogate outcomes are a significant challenge in drug evaluation for health technology assessment (HTA) agencies. The research objectives were to: identify factors associated with surrogate use and acceptability in Canada’s Common Drug Review (CDR) recommendations, and compare the CDR with other HTA or regulatory agencies regarding surrogate concerns.MethodsFinal recommendations were identified from CDR inception (September 2003) to …
Authors
Rocchi A; Khoudigian S; Hopkins R; Goeree R
Journal
Cost Effectiveness and Resource Allocation, Vol. 11, No. 1,
Publisher
Springer Nature
Publication Date
2013
DOI
10.1186/1478-7547-11-31
ISSN
1478-7547